BG
CRTX

BlackRock Group’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

BlackRock Group’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-61,464
Closed -$578K – 2921
2013
Q3 		$578K Buy
+61,464
New +$554K ﹤0.01% 2175

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

BlackRock Group's CRTX Position: Q4 2013 in Review

BlackRock Group sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q4 2013, closing a stake of 61,464 shares — an estimated $578K sold.

BlackRock Group first reported a position in CRTX in Q3 2013 and held it in 1 quarter. The position peaked at $578K in Q3 2013. 62 funds tracked by Wall St. Rank hold CRTX as of Q4 2013.

  • BlackRock Group reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 61,464 CORNERSTONE THERAPEUTICS INC shares in Q4 2013, an estimated $578K.
  • BlackRock Group first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 1 quarter.
  • BlackRock Group's CORNERSTONE THERAPEUTICS INC position peaked at $578K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.